Skip to main content
. 2016 Aug 9;7(10):884–889. doi: 10.1021/acsmedchemlett.6b00188

Figure 1.

Figure 1

sPLA2 inhibitor varespladib methyl, its active metabolite varespladib, and initial fragment hit 1.